Lyra Therapeutics, Inc. (LYRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 47.85M |
| Enterprise Value | 62.21M |
| P/E Ratio | -0.02 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.96 |
| Price/Book Ratio | -0.64 |
| Enterprise/Revenue | 38.06 |
| Enterprise/EBITDA | -0.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -72.66 |
| Operating Margin | -77.94 |
| Return On Assets | -0.8 |
| Return On Equity | 12.11 |
| Revenue | 398,000 |
| Revenue/Share | 0.03 |
| Gross Profit | 398,000 |
| EBITDA | -29.09M |
| Net Income | -28.92M |
| Diluted EPS | -18.62 |
| Total Cash | 15.89M |
| Total Cash/Share | 1.02 |
| Total Debt | 30.26M |
| Total Debt/Equity | -2.82 |
| Current Ratio | 1.71 |
| Book Value Per Share | -0.69 |
| 52-Week Change | -89.81 |
| 52-Week High | 37.5 |
| 52-Week Low | 0.44 |
| Moving Average 50 Days | 1.82 |
| Moving Average 200 Days | 5.95 |
| Average Volume | 106,352 |
| Shares Outstanding | 1.77M |
| % Held by Institutions | 1.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | May 28, 2025 |